{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T14:03:58Z","timestamp":1775829838231,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002879","name":"Canadian HIV Trials Network, Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CTN222"],"award-info":[{"award-number":["CTN222"]}],"id":[{"id":"10.13039\/501100002879","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes for Health Research","doi-asserted-by":"crossref","award":["FDN-143270"],"award-info":[{"award-number":["FDN-143270"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Public Health"],"DOI":"10.17269\/s41997-026-01193-y","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T13:21:56Z","timestamp":1775827316000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The risk of HIV and HCV transmission in Canadians living with coinfection before, during, and after the COVID pandemic: A prospective cohort study"],"prefix":"10.17269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4314-3007","authenticated-orcid":false,"given":"Jim","family":"Young","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Knight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudette L.","family":"Cardinal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis L.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Hull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Martel-Laferriere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dessie J.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Walmsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3063-8430","authenticated-orcid":false,"given":"Marina B.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Canadian Coinfection Cohort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Conway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"C\u00f4t\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shariq","family":"Haider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Hull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Martel-Laferriere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neora","family":"Pick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Louise","family":"Vachon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Walmsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"1193_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/13558196241287336","volume":"30","author":"JAK Alhassan","year":"2025","unstructured":"Alhassan, J. A. K., Rohatinsky, N., Peru, T., Levandoski, C., Kendel, D., Dmytrowich, J., et al. (2025). Health care providers\u2019 perceptions of burnout and moral distress during the COVID-19 pandemic: A qualitative study from Saskatchewan, Canada. Journal of Health Services Research & Policy, 30, 109\u2013116.","journal-title":"Journal of Health Services Research & Policy"},{"key":"1193_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/jac\/dkae407","volume":"80","author":"K Andreatta","year":"2025","unstructured":"Andreatta, K., Sax, P. E., Wohl, D., D\u2019Antoni, M. L., Liu, H., Hindman, J. T., et al. (2025). Efficacy of bictegravir\/emtricitabine\/tenofovir alafenamide versus dolutegravir-based three-drug regimens in people with HIV with varying adherence to antiretroviral therapy. Journal of Antimicrobial Chemotherapy, 80, 281\u2013291.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"1193_CR3","doi-asserted-by":"publisher","first-page":"432","DOI":"10.17269\/s41997-024-00888-4","volume":"115","author":"H Apelian","year":"2024","unstructured":"Apelian, H., Aho, J., Wong, E., & Cox, J. (2024). The impact of the COVID-19 pandemic on social determinants of health, mental health, and substance use among key populations affected by sexually transmitted and blood-borne infections in Canada. Canadian Journal of Public Health, 115, 432\u2013442.","journal-title":"Canadian Journal of Public Health"},{"key":"1193_CR4","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1097\/QAD.0b013e328340a209","volume":"24","author":"DR Bangsberg","year":"2010","unstructured":"Bangsberg, D. R., Ragland, K., Monk, A., & Deeks, S. G. (2010). A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people. AIDS, 24, 2835\u20132840.","journal-title":"AIDS"},{"key":"1193_CR5","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1111\/liv.15074","volume":"41","author":"M Binka","year":"2021","unstructured":"Binka, M., Bartlett, S., Velasquez Garcia, H. A., Darvishian, M., Jeong, D., Adu, P., et al. (2021). Impact of COVID-19-related public health measures on HCV testing in British Columbia, Canada: An interrupted time series analysis. Liver International, 41, 2849\u20132856.","journal-title":"Liver International"},{"key":"1193_CR6","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1016\/j.csda.2011.06.011","volume":"55","author":"G Brostrom","year":"2011","unstructured":"Brostrom, G., & Holmberg, H. (2011). Generalized linear models with clustered data: Fixed and random effects models. Computational Statistics & Data Analysis, 55, 3123\u20133134.","journal-title":"Computational Statistics & Data Analysis"},{"key":"1193_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S0140-6736(23)00877-2","volume":"402","author":"LN Broyles","year":"2023","unstructured":"Broyles, L. N., Luo, R., Boeras, D., & Vojnov, L. (2023). The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: A systematic review. Lancet, 402, 464\u2013471.","journal-title":"Lancet"},{"key":"1193_CR8","doi-asserted-by":"publisher","DOI":"10.1177\/13596535211062396","volume":"27","author":"MC Choudhary","year":"2022","unstructured":"Choudhary, M. C., & Mellors, J. W. (2022). The transformation of HIV therapy: One pill once a day. Antiviral Therapy, 27, Article 10.1177\/13596535211062396.","journal-title":"Antiviral Therapy"},{"key":"1193_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.drugalcdep.2014.01.014","volume":"137","author":"J Cox","year":"2014","unstructured":"Cox, J., Maurais, E., Hu, L., Moodie, E. E., Law, S., Bozinoff, N., et al. (2014). Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection Cohort. Drug and Alcohol Dependence, 137, 121\u2013128.","journal-title":"Drug and Alcohol Dependence"},{"key":"1193_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104026","author":"CL Delaunay","year":"2023","unstructured":"Delaunay, C. L., Klein, M. B., Godin, A., Cox, J., Kronfli, N., Lebouche, B., et al. (2023). Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling study. International Journal of Drug Policy. https:\/\/doi.org\/10.1016\/j.drugpo.2023.104026","journal-title":"International Journal of Drug Policy"},{"key":"1193_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3138\/canlivj-2024-0042","volume":"8","author":"MZ El Sheikh","year":"2025","unstructured":"El Sheikh, M. Z., Young, J., Panagiotoglou, D., Cooper, C., Cox, J., Martel-Laferriere, V., et al. (2025). Progress toward hepatitis C virus elimination among people living with HIV-hepatitis C virus coinfection in Canada. Canadian Liver Journal, 8, 49\u201362.","journal-title":"Canadian Liver Journal"},{"key":"1193_CR12","first-page":"493","volume":"5","author":"JJ Feld","year":"2022","unstructured":"Feld, J. J., Klein, M. B., Rahal, Y., Lee, S. S., Mohammed, S., King, A., et al. (2022). Timing of elimination of hepatitis C virus in Canada\u2019s provinces. Canadian Liver Journal, 5, 493\u2013506.","journal-title":"Canadian Liver Journal"},{"key":"1193_CR13","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/hiv.13654","volume":"25","author":"E Finlayson-Trick","year":"2024","unstructured":"Finlayson-Trick, E., Tam, C., Wang, L., Dawydiuk, N., Salters, K., Trigg, J., et al. (2024). Access to care and impact on HIV treatment interruptions during the COVID-19 pandemic among people living with HIV in British Columbia. HIV Medicine, 25, 1007\u20131018.","journal-title":"HIV Medicine"},{"key":"1193_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2242-y","author":"C Greenaway","year":"2017","unstructured":"Greenaway, C., Azoulay, L., Allard, R., Cox, J., Tran, V. A., Abou Chakra, C. N., et al. (2017). A population-based study of chronic hepatitis C in immigrants and non-immigrants in Quebec, Canada. BMC Infectious Diseases. https:\/\/doi.org\/10.1186\/s12879-017-2242-y","journal-title":"BMC Infectious Diseases"},{"key":"1193_CR15","unstructured":"Hall, K. S., Trecker, M., Craddock, S., Lang, R., Myrah, D., Karunakaran, K. et al. (2023). High pandemic-related mortality amongst people with HIV in Saskatchewan, Canada. Conference on Retroviruses and Opportunistic Infections, February 19\u201322, 2023 [On-line]. Available: https:\/\/www.croiconference.org\/abstract\/high-pandemic-related-mortality-amongst-people-with-hiv-in-saskatchewan-canada\/"},{"key":"1193_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3138\/canlivj-2024-0016","volume":"8","author":"SX Jiang","year":"2025","unstructured":"Jiang, S. X., Feizi, J., Chan, B., Tam, E., MacIsaac, J., Ko, H. H., et al. (2025). Simplified treatment of hepatitis C during the COVID-19 pandemic: Retrospective analysis of the British Columbia Hepatitis C Network. Canadian Liver Journal, 8, 29\u201338.","journal-title":"Canadian Liver Journal"},{"key":"1193_CR17","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/ije\/dyp297","volume":"39","author":"MB Klein","year":"2010","unstructured":"Klein, M. B., Saeed, S., Yang, H., Cohen, J., Conway, B., Cooper, C., et al. (2010). Cohort profile: The Canadian HIV-hepatitis C co-infection cohort study. International Journal of Epidemiology, 39, 1162\u20131169.","journal-title":"International Journal of Epidemiology"},{"key":"1193_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/14659891.2021.1941341","volume":"27","author":"J Klimas","year":"2022","unstructured":"Klimas, J., Mok, W. Y., Lake, S., Eugenia, S. M., DeBeck, K., Hayashi, K., et al. (2022). Prevalence and correlates of intentional substance use to reduce illicit opioid use in a Canadian setting. Journal of Substance Use, 27, 277\u2013282.","journal-title":"Journal of Substance Use"},{"key":"1193_CR19","doi-asserted-by":"publisher","DOI":"10.17269\/s41997-025-00997-8","author":"A Kroch","year":"2025","unstructured":"Kroch, A., Gogolishvili, D., O\u2019Brien, K., Orser, L., Woodward, K., Tharao, W., et al. (2025). The evolving HIV epidemic in Ontario, Canada: A retrospective analysis of new HIV diagnoses to identify subpopulations with persistent risk of HIV transmission. Canadian Journal of Public Health. https:\/\/doi.org\/10.17269\/s41997-025-00997-8","journal-title":"Canadian Journal of Public Health"},{"key":"1193_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-8052-y","author":"N Kronfli","year":"2019","unstructured":"Kronfli, N., Linthwaite, B., Sheehan, N., Cox, J., Hardy, I., Lebouche, B., et al. (2019). Delayed linkage to HIV care among asylum seekers in Quebec, Canada. BMC Public Health. https:\/\/doi.org\/10.1186\/s12889-019-8052-y","journal-title":"BMC Public Health"},{"key":"1193_CR21","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/cid\/ciaa702","volume":"73","author":"N Kronfli","year":"2021","unstructured":"Kronfli, N., Young, J., Wang, S., Cox, J., Walmsley, S., Hull, M., et al. (2021). Liver fibrosis in human immunodeficiency virus (HIV)-hepatitis C virus (HCV) coinfection before and after sustained virologic response: What is the best noninvasive marker for monitoring regression? Clinical Infectious Diseases, 73, 468\u2013477.","journal-title":"Clinical Infectious Diseases"},{"key":"1193_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11524-017-0225-3","volume":"95","author":"S Lake","year":"2018","unstructured":"Lake, S., Kerr, T., Nosova, E., Milloy, M. J., Wood, E., & DeBeck, K. (2018). Patterns of non-injection drug use associated with injection cessation among street-involved youth in Vancouver, Canada. Journal of Urban Health, 95, 267\u2013277.","journal-title":"Journal of Urban Health"},{"key":"1193_CR23","unstructured":"Lambert, G., Dvorakova.M, Fourmigue, A., Apelian, H., & Cox, J. (2025). Engage Montr\u00e9al, Portrait de la sant\u00e9 sexuelle des hommes de la r\u00e9gion m\u00e9tropolitaine de Montr\u00e9al ayant des relations sexuelles avec des hommes: Faits saillants de la cohorte 2017\u20132023. Direction r\u00e9gionale de sant\u00e9 publique de Montr\u00e9al et Institut de Recherche du Centre Universitaire de Sant\u00e9 de McGill [On-line]. Available: https:\/\/www.engage-men.ca\/engage-cohort-study-highlights-2017-2023\/"},{"key":"1193_CR24","doi-asserted-by":"publisher","DOI":"10.1177\/23259582221140208","author":"F Maggiolo","year":"2022","unstructured":"Maggiolo, F., Valenti, D., Teocchi, R., Comi, L., Di Filippo, E. M., & Rizzi, M. (2022). Real world data on forgiveness to uncomplete adherence to bictegravir\/ emtricitabine\/tenofovir alafenamide. Journal of the International Association of Providers of AIDS Care (JIAPAC). https:\/\/doi.org\/10.1177\/23259582221140208","journal-title":"Journal of the International Association of Providers of AIDS Care (JIAPAC)"},{"key":"1193_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2024.116920","author":"LL Munasinghe","year":"2024","unstructured":"Munasinghe, L. L., Yin, W., Nathani, H., Toy, J., Sereda, P., Barrios, R., et al. (2024). The impact of the COVID-19 pandemic on HIV treatment gap lengths and viremia among people living with HIV British Columbia, Canada, during the COVID-19 pandemic: Are we ready for the next pandemic? Social Science & Medicine. https:\/\/doi.org\/10.1016\/j.socscimed.2024.116920","journal-title":"Social Science & Medicine"},{"key":"1193_CR26","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.230249","author":"TJ Murphy","year":"2023","unstructured":"Murphy, T. J., Swail, H., Jain, J., Anderson, M., Awadalla, P., Behl, L., et al. (2023). The evolution of SARS-CoV-2 seroprevalence in Canada: A time-series study, 2020-2023. Canadian Medical Association Journal. https:\/\/doi.org\/10.1503\/cmaj.230249","journal-title":"Canadian Medical Association Journal"},{"key":"1193_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.drugpo.2018.08.012","volume":"65","author":"R Nitulescu","year":"2019","unstructured":"Nitulescu, R., Young, J., Saeed, S., Cooper, C., Cox, J., Martel-Laferriere, V., et al. (2019). Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antivirals. International Journal of Drug Policy, 65, 41\u201349.","journal-title":"International Journal of Drug Policy"},{"key":"1193_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249836","author":"A Palayew","year":"2021","unstructured":"Palayew, A., Schmidt, A. M., Saeed, S., Cooper, C. L., Wong, A., Martel-Laferriere, V., et al. (2021). Estimating an individual-level deprivation index for HIV\/HCV coinfected persons in Canada. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0249836","journal-title":"PLoS One"},{"key":"1193_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.drugpo.2019.08.003","volume":"74","author":"ME Pearce","year":"2019","unstructured":"Pearce, M. E., Jongbloed, K., Demerais, L., MacDonald, H., Christian, W. M., Sharma, R., et al. (2019). Another thing to live for\u201d: Supporting HCV treatment and cure among Indigenous people impacted by substance use in Canadian cities. International Journal of Drug Policy, 74, 52\u201361.","journal-title":"International Journal of Drug Policy"},{"key":"1193_CR30","unstructured":"Public Health Agency of Canada (2022). National report: Findings from the survey on the impact of COVID-19 on the delivery of STBBI prevention, testing and treatment, including harm reduction services, in Canada. Public Health Agency of Canada [On-line]. Available: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/survey-impact-covid-19-delivery-stbbi-prevention-testing-treatment.html"},{"key":"1193_CR31","unstructured":"Public Health Agency of Canada (2023). Chlamydia, gonorrhea and infectious syphilis in Canada: 2021 surveillance data update. Public Health Agency of Canada [On-line]. Available: https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/documents\/services\/publications\/diseases-conditions\/chlamydia-gonorrhea-infectious-syphilis-2021-surveillance-data\/chlamydia-gonorrhea-infectious-syphilis-2021-surveillance-data.pdf"},{"key":"1193_CR32","unstructured":"Public Health Agency of Canada (2024a). Canada\u2019s progress towards eliminating viral hepatitis as a public health concern. Public Health Agency of Canada [On-line]. Available: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/progress-towards-eliminating-viral-hepatitis-threat-2021.html"},{"key":"1193_CR33","unstructured":"Public Health Agency of Canada (2024b). Canada\u2019s progress towards ending the HIV epidemic, 2022. Public Health Agency of Canada [On-line]. Available: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/canada-progress-towards-ending-hiv-epidemic-2022.html"},{"key":"1193_CR34","unstructured":"Public Health Agency of Canada (2024c). Government of Canada\u2019s sexually transmitted and blood-borne infections (STBBI) action plan 2024\u20132030. Public Health Agency of Canada [On-line]. Available: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/sexually-transmitted-blood-borne-infections-action-plan-2024-2030.html"},{"key":"1193_CR35","unstructured":"Public Health Agency of Canada (2024d). Hepatitis C in Canada: 2021 surveillance data update. Public Health Agency of Canada [On-line]. Available: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/hepatitis-c-canada-2021-surveillance-data-update.html"},{"key":"1193_CR36","unstructured":"Public Health Agency of Canada (2024e). HIV in Canada: 2023 surveillance highlights. Public Health Agency of Canada [On-line]. Available: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/hiv-2023-surveillance-highlights-infographic.html"},{"key":"1193_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0315880","author":"N Rehman","year":"2025","unstructured":"Rehman, N., Mbuagbaw, L., Mertz, D., Muraca, G. M., & Jones, A. (2025). Association between virtual visits and health outcomes of people living with HIV: A cross-sectional study. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0315880","journal-title":"PLoS One"},{"key":"1193_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3138\/jammi-2024-0026","volume":"10","author":"ZV Rueda","year":"2025","unstructured":"Rueda, Z. V., Arroyave, L., Herrera, M., Singh, A. E., Skinner, S., Spence, C., et al. (2025). Evolution and possible explanations for the trends in new HIV diagnoses in Alberta, Saskatchewan, and Manitoba, compared to the rest of Canada, 1985-2022. Journal of the Association of Medical Microbiology and Infectious Disease Canada, 10, 15\u201331.","journal-title":"Journal of the Association of Medical Microbiology and Infectious Disease Canada"},{"key":"1193_CR39","unstructured":"Rutty, C. (2023). COVID-19 pandemic in Canada. The Canadian Encyclopedia [On-line]. Available: https:\/\/www.thecanadianencyclopedia.ca\/en\/article\/covid-19-pandemic"},{"key":"1193_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25013","author":"S Saeed","year":"2017","unstructured":"Saeed, S., Strumpf, E. C., Moodie, E. E., Young, J., Nitulescu, R., Cox, J., et al. (2017). Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada. Journal of the International AIDS Society. https:\/\/doi.org\/10.1002\/jia2.25013","journal-title":"Journal of the International AIDS Society"},{"key":"1193_CR41","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1007\/s11469-022-00932-9","volume":"22","author":"J Snowdon","year":"2024","unstructured":"Snowdon, J., & Choi, N. (2024). Unanticipated changes in drug overdose death rates in Canada during the opioid crisis. International Journal of Mental Health and Addiction, 22, 1394\u20131412.","journal-title":"International Journal of Mental Health and Addiction"},{"key":"1193_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-025-12514-1","author":"C Sobie","year":"2025","unstructured":"Sobie, C., Maier, K., Haworth-Brockman, M., Villacis-Alvarez, E., Keynan, Y., & Rueda, Z. V. (2025). We really need to surround people with care: \u201d A qualitative examination of service providers\u2019 perspectives on barriers to HIV care in Manitoba, Canada. BMC Health Services Research. https:\/\/doi.org\/10.1186\/s12913-025-12514-1","journal-title":"BMC Health Services Research"},{"key":"1193_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijregi.2024.100433","author":"M Sorokopud-Jones","year":"2024","unstructured":"Sorokopud-Jones, M., Sharp, A., Haworth-Brockman, M., Kasper, K., MacKenzie, L., Ireland, L., et al. (2024). Sexually transmitted and blood-borne infections by sex, methamphetamine use, and houselessness before, at, and after HIV diagnosis in Manitoba, Canada. IJID Regions. https:\/\/doi.org\/10.1016\/j.ijregi.2024.100433","journal-title":"IJID Regions"},{"key":"1193_CR44","doi-asserted-by":"publisher","first-page":"194","DOI":"10.17269\/s41997-024-00991-6","volume":"116","author":"W Tharao","year":"2025","unstructured":"Tharao, W., Nyoni, T., Daftary, A., Bullock, S., Blot, S., Pierre-Pierre, V., et al. (2025). Post-arrival HIV acquisition patterns: Insights from African, Caribbean, and Black immigrant communities in Canada. Canadian Journal of Public Health, 116, 194\u2013208.","journal-title":"Canadian Journal of Public Health"},{"key":"1193_CR45","doi-asserted-by":"crossref","unstructured":"Verbeke, G., Molenberghs, G., & Rizopoulos, D. (2010). Random effects models for longitudinal data. In K. van Montfort, J. H. L. Oud, & A. Satorra (Eds.),","DOI":"10.1007\/978-3-642-11760-2_2"},{"key":"1193_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pdig.0000857","author":"SL Walmsley","year":"2025","unstructured":"Walmsley, S. L., Nabipoor, M., Martel-Laferriere, V., Loutfy, M., Cooper, C., Vachon, M. L., et al. (2025). Evaluation of the virtual care experience for persons in prospective cohorts with HIV during the COVID pandemic. PLoS Digital Health. https:\/\/doi.org\/10.1371\/journal.pdig.0000857","journal-title":"PLoS Digital Health"},{"key":"1193_CR47","unstructured":"Weingarten, N. & McGillivray, K. (2025). Despite \u2018massive shift\u2019 towards smoking over injection, Ontario has only 1 supervised drug inhalation space. CBC News [On-line]. Available: https:\/\/www.cbc.ca\/news\/canada\/toronto\/smoking-over-injecting-opioids-inhalation-safety-1.7558607"},{"key":"1193_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.103981","author":"J Young","year":"2023","unstructured":"Young, J., Wang, S., Laniece, D. C., Cooper, C. L., Cox, J., Gill, M. J., et al. (2023). The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national elimination. International Journal of Drug Policy. https:\/\/doi.org\/10.1016\/j.drugpo.2023.103981","journal-title":"International Journal of Drug Policy"}],"container-title":["Canadian Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.17269\/s41997-026-01193-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.17269\/s41997-026-01193-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.17269\/s41997-026-01193-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T13:22:10Z","timestamp":1775827330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.17269\/s41997-026-01193-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":48,"alternative-id":["1193"],"URL":"https:\/\/doi.org\/10.17269\/s41997-026-01193-y","relation":{},"ISSN":["0008-4263","1920-7476"],"issn-type":[{"value":"0008-4263","type":"print"},{"value":"1920-7476","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research has been approved by the research ethics boards of all participating institutions and by the Community Advisory Committee of the Canadian HIV Trials Network.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants gave written informed consent in accordance with the ethical standards of the Helsinki Declaration.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable. The manuscript contains summary data only and no individual data or image.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Cooper has served as a consultant and speaker for Abbvie and Gilead Sciences. He has received unrestricted research and program funds from Abbvie and Gilead Sciences. Cox has received grants to his institution for research from ViiV Healthcare, Gilead Sciences, Abbvie, and IQVIA, all outside of the submitted work, and speaker fees from ViiV Healthcare and Gilead Sciences. Hull has received honouraria for speaking engagements or advisory boards and research funding from Gilead Sciences. Martel-Laferriere served as an advisor for Abbvie and has a grant from Gilead Sciences and is funded as FRQ (Sant\u00e9) Research Scholar by a Chercheur-boursier clinicien junior award. Walmsley has received funding from ViiV Healthcare, Merck, and Gilead Sciences for investigator-initiated studies and consulting fees for advisory boards and speaking at CME events. She is supported by the Speck Family Chair in emerging infectious diseases. Wong has received research grants from ViiV HealthCare, AbbVie, and Gilead Sciences and consulting fees from ViiV Healthcare, AbbVie, Merck, and Gilead Sciences. Klein reports grants for investigator-initiated studies from ViiV Healthcare, AbbVie, and Gilead Sciences and consulting fees from ViiV Healthcare, AbbVie, and Gilead Sciences, all outside the submitted work, and is supported by a Tier I Canada Research Chair. Young, Wang, Knight, Cardinal, and Sutherland all declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}